Princeton Junction, NJ, United States of America

Ming Lei

This inventor holds 88 USPTO granted patents and 10 published patent applications and 6 EPO patents, primarily in Chimeric Antigen Receptors (CPC class G06K7-10732). Top assignees: The Code Corporation, Novartis Ag, University of Pennsylvania. Active years: 2010-2026.

USPTO Granted Patents = 88 (Patent Applications = 10)

% Patents Active = 87.5

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 2.9

ph-index = 9

Forward Citations = 282(Granted Patents)

Forward Citations (Not Self Cited) = 234(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Cambridge, MA (US) (2019)
Princeton Junction, NJ (US) (2014 - 2022)
Taylorsville, NJ (US) (2019 - 2022)
Concord, MA (US) (2023)
Acton, MA (US) (2010 - 2024)

Company Filing History:

University of Pennsylvania

patents

4. 4 out of 47

Microscan Systems Incorporated

patents

5. 1 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Chimeric Antigen Receptors

CD20 Binding Domain

Barcode Reading System

Data Validation

Illumination System

Motion Detection

Nucleic Acid Molecules

Mobile Device Application

Efficiency in Barcode Reading

Combination Therapies

Firmware Retrieval

Optics for Imaging

88 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12594321 - Bispecific chimeric antigen receptor that binds CD19 and CD20, encoding nucleic acid molecules thereof and methods of use thereof to treat cancer (2026-04-07),

2. 12344657 - CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell (2025-07-01),

3. 12164997 - Barcode-reading application that is designed for a general-purpose computing device and that includes a motion detection module (2024-12-10),

4. RE49847 - Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain (2024-02-27),

5. 11872249 - Method of treating cancer by administering immune effector cells expressing a chimeric antigen receptor comprising a CD20 binding domain (2024-01-16),

6. 11809946 - Data collection for barcode-reading devices (2023-11-07),

7. 11361183 - Architecture for faster decoding in a barcode reading system that includes a slow interface between the camera and decoder (2022-06-14),

8. 11361179 - Barcode reading system having a legacy mobile client function, a non-legacy mobile client function, and a relay function (2022-06-14),

9. 11163856 - Offline license activation for barcode decoders (2021-11-02),

10. 11149076 - CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell (2021-10-19),

11. 11080497 - Attachment including a targeting optic system that directs illumination from a white light source towards a target area (2021-08-03),

12. 11080369 - Enterprise-level licensing for a barcode decoder within a mobile device application (2021-08-03),

13. 11076021 - Host device for obtaining operating instructions for a barcode reader from a remote server (2021-07-27),

14. 11036951 - Architecture for faster decoding in a barcode reading system that includes a slow interface between the camera and decoder (2021-06-15),

15. 11036948 - Barcode-scanning system configured for both data validation and data formatting (2021-06-15),

Title: The Innovative Journey of Ming Lei

Introduction: Ming Lei, a talented inventor hailing from Princeton Junction, NJ, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Ming Lei's latest patents include a cutting-edge artificial intelligence algorithm for predictive analytics and a revolutionary wearable device for monitoring vital signs in real-time.

Career Highlights: With a career spanning over two decades, Ming Lei has established himself as a visionary in the tech industry. He has held key positions in several renowned tech companies, leading research and development teams to create innovative solutions.

Collaborations: Ming Lei has collaborated with top universities and research institutions to further his research and bring his inventions to life. His partnerships have resulted in the successful development of products that have positively impacted various sectors.

Conclusion: Ming Lei's passion for innovation and his relentless drive to push the boundaries of technology have solidified his position as a respected inventor in the industry. His dedication to creating cutting-edge solutions continues to inspire the next generation of inventors.